Yahoo Malaysia Web Search

Search results

  1. www.bachem.comBachem

    Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive ...

    • Products & Services

      Bachem offers more than 5000 different biologically active...

    • About Bachem

      Bachem is a leading, innovation-driven company specializing...

    • News & Events

      As Bachem is the world’s leading company in developing and...

    • Knowledge Center

      Bachem provides a wide range of documentation and practical...

    • Careers

      Bachem is committed to working with and providing reasonable...

    • Contact

      Bachem AG Hauptstrasse 144 4416 Bubendorf Switzerland. Tel...

    • CMC Development

      Certainly, Bachem's expertise in peptides, their...

    • Commercial API

      You come first – We pride ourselves on a consistently high...

  2. Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals.

  3. Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a ...

  4. www.bachem.com › about-bachem › company-overviewCompany overview - Bachem

    Find out about Bachem's purpose, vision and strategy, leadership, history and where we are located.

  5. Get the latest BACHEM HOLDING AG (BANB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  6. BACHEM AT THE CPHI TRADE FAIR IN BARCELONA Bachem presents solutions for scalable oligonucle-otide production and oligonucleotide quality control. JULY 27 SLIGHT SALES GROWTH IN THE FIRST HALF OF 2023 Group sales increase to CHF 239.9˜million (+2.1%, +5.3% in local currencies). EBITDA margin of 21.9%. JUNE 24 BACHEM AT THE AMERICAN PEPTIDE

  7. As Bachem is the world’s leading company in developing and manufacturing peptides and oligonucleotides, we receive a lot of interest about our company news and activities. Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.